Catalent Inc (NYSE:CTLT)
| 44.28 BATS BZX Real-Time Price As of 1:12pm ET |  -1.25 / -2.75%Today’s Change | 31.45 Today|||52-Week Range 81.72 | -1.62% Year-to-Date |
Latest CTLT News | Press Releases
| Revvity's (RVTY) New Launch to Widen Access to Editing Technology 10:10am / Zacks.com - Paid Partner Content | 3 Reasons to Hold Catalent (CTLT) Stock in Your Portfolio Sep 27 / Zacks.com - Paid Partner Content |
| Catalent (CTLT) Down 6.5% Since Last Earnings Report: Can It Rebound? Sep 28 / Zacks.com - Paid Partner Content | Is Catalent (CTLT) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap Sep 26 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 45.53 |
| Today’s open | 45.29 |
| Day’s range | 44.21 - 45.31 |
| Volume | 339,156 |
| Average volume (3 months) | 2,845,671 |
| Market cap | $8.2B |
Data as of 1:12pm ET, 10/02/2023
Growth & Valuation
| Earnings growth (last year) | -144.85% |
| Earnings growth (this year) | +28.71% |
| Earnings growth (next 5 years) | -4.00% |
| Revenue growth (last year) | -11.43% |
| P/E ratio | 192.3 |
| Price/Sales | 1.84 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JAZZJazz Pharmaceuticals... | -1.05 | -0.81% |
| RGENRepligen Corp | -4.22 | -2.66% |
| ---- | ||
| ---- |
Data as of 12:56pm ET, 10/02/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $4.3B |
| Annual profit (last year) | -$232.0M |
| Net profit margin | -5.43% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Somerset, New Jersey |
Forecasts
